Risk factor of contralateral radiculopathy following microendoscopy-assisted minimally invasive transforaminal lumbar interbody fusion

Y Yang, ZY Liu, LM Zhang, JW Dong, PG Xie… - European Spine …, 2018 - Springer
Purpose Microendoscopy-assisted minimally invasive transforaminal lumbar interbody
fusion (MIS-TLIF) is an advantageous method for treating lumbar degenerative disease; …
被引用次数：26 相关文章

Risk factor of contralateral radiculopathy following microendoscopy-assisted minimally invasive transforaminal lumbar interbody fusion

Y Yang, L Zhong-Yu, Z Liang-Ming… - European Spine …, 2018 - search.proquest.com
Purpose Microendoscopy-assisted minimally invasive transforaminal lumbar interbody
fusion (MIS-TLIF) is an advantageous method for treating lumbar degenerative disease; …

Risk factor of contralateral radiculopathy following microendoscopy-assisted minimally invasive transforaminal lumbar interbody fusion.

Y Yang, ZY Liu, LM Zhang, JW Dong… - … Spine Journal: Official …, 2017 - europepmc.org
Purpose Microendoscopy-assisted minimally invasive transforaminal lumbar interbody
fusion (MIS-TLIF) is an advantageous method for treating lumbar degenerative disease; …

Risk factor of contralateral radiculopathy following microendoscopy-assisted minimally invasive transforaminal lumbar interbody fusion

Y Yang, ZY Liu, LM Zhang, JW Dong… - … publication of the …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose Microendoscopy-assisted minimally invasive transforaminal lumbar interbody
fusion (MIS-TLIF) is an advantageous method for treating lumbar degenerative disease; …
[PDF] academia.edu

[PDF][PDF] Risk factor of contralateral radiculopathy following microendoscopy‑assisted minimally invasive transforaminal lumbar interbody fusion

Y Yang, ZY Liu, LM Zhang, JW Dong, PG Xie, RQ Chen… - 2017 - academia.edu
Purpose Microendoscopy-assisted minimally invasive transforaminal lumbar interbody
fusion (MIS-TLIF) is an advantageous method for treating lumbar degenerative disease; …